IDEAYA Biosciences (IDYA) Other Non-Current Assets (2018 - 2026)

IDEAYA Biosciences (IDYA) reported Other Non-Current Assets of $1.3 million for Q1 2026, up 59.13% on a YoY basis from $805000.0 in Q1 2025, and up 26.21% sequentially from $1.0 million in Q4 2025.

IDEAYA Biosciences (IDYA) Other Non-Current Assets (2018 - 2026) Analysis & Trends

IDEAYA Biosciences (IDYA) has 9 years of Other Non-Current Assets data on file, last reported at $1.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets rose 59.13% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 59.13% YoY), and the FY2025 full-year result was $1.0 million, up 26.09% from the prior year.
  • Other Non-Current Assets rose to $1.3 million in Q1 2026, from $1.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.3 million in Q1 2026 to a low of $106000.0 in Q1 2022.
  • A 5-year average of $636823.5 and a median of $757000.0 in 2023 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets slumped 63.57% in 2022 and soared 614.15% in 2023, its largest moves.
  • Tracing IDYA's Other Non-Current Assets over 5 years: stood at $106000.0 in 2022, then soared by 614.15% to $757000.0 in 2023, then rose by 6.34% to $805000.0 in 2024, then climbed by 26.09% to $1.0 million in 2025, then climbed by 26.21% to $1.3 million in 2026.
  • Business Quant data shows IDYA's Other Non-Current Assets at $1.3 million in Q1 2026, $1.0 million in Q4 2025, and $805000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 IDEAYA Biosciences 3.21 Bn 2.54 Bn - 1.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.28 Mn
Dec 31, 2025 1.02 Mn
Sep 30, 2025 805,000.00
Jun 30, 2025 805,000.00
Mar 31, 2025 805,000.00
Dec 31, 2024 805,000.00
Sep 30, 2024 911,000.00
Jun 30, 2024 911,000.00
Mar 31, 2024 757,000.00
Dec 31, 2023 757,000.00
Sep 30, 2023 722,000.00
Jun 30, 2023 722,000.00
Mar 31, 2023 106,000.00
Dec 31, 2022 106,000.00
Sep 30, 2022 106,000.00
Jun 30, 2022 106,000.00
Mar 31, 2022 106,000.00
Dec 31, 2021 291,000.00
Sep 30, 2021 217,000.00
Jun 30, 2021 106,000.00